Clinical Trial Update: A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study evaluating safety and tolerability of PP 1420 in healthy subjects; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PP 1420

Snippet

Sponsor: Imperial College London | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2021-02-12